Pass the Salesforce Salesforce Consultant Als-Con-201 Questions and answers with CertsForce

Option B is correct because Salesforce Life Sciences Medical Inquiries uses workflow actions and persona/profile-based configuration to control who can perform specific inquiry actions, such as assigning and responding. Salesforce Help states that, before setting up Medical Inquiry, admins must make sure the required user profiles, licenses, and permission sets are in place. It also describes that medical science liaisons can assign and respond to inquiries, which confirms that these actions are intended to be controlled by role or persona.

Salesforce’s Life Sciences workflow documentation also identifies workflow actions and workflow stages as part of the Medical Inquiry management setup. The Medical Inquiries workflow setup includes action buttons, workflow stages, stage operations, and conditions, allowing admins to expose or restrict actions based on configured roles and workflow state.

Option A is not the best answer because the requirement is not simply to grant a broad app permission; it is to ensure that only a designated persona can perform the assign and respond actions in the controlled Medical Inquiry process. Option C is incorrect because a custom formula field only affects display logic and does not enforce the standard workflow-action permission model. Formula-based visibility also creates compliance risk because it can hide buttons without truly governing the underlying operation. Therefore, the consultant should create workflow actions and associate those actions with the appropriate profiles in the Life Sciences Admin Console.

=========

Option B is correct because the requirement is specifically to prevent visit creation when a Visit overlaps with a Time Off Territory record. Salesforce Life Sciences documentation references Time Off Territory overlapping rules as the standard mechanism that prevents creating visits during TOT events. Salesforce’s Winter ’26 Customer Engagement package patch notes also mention an issue where a visit could be created during a Time Off Territory event, bypassing the overlapping rule that should have prevented creation. That confirms TOT overlapping rules are the expected standard control for this scenario.

Because the business wants a hard stop, the overlapping rule behavior must be set to “Error.” This means the rep receives an error and cannot proceed with scheduling the visit while it conflicts with the TOT time block.

Option A is incorrect because a custom validation rule on Visit would duplicate a standard Life Sciences calendar/TOT capability and may not handle the full mobile scheduling experience correctly. Option C is also not the best answer because “Block Activity on Conflict” on the TOT record type is not the documented standard configuration in the Life Sciences Visit/Calendar settings. The correct standard configuration is to use TOT Overlapping Rules and set the overlap behavior to Error. This prevents scheduling visits during the rep’s logged time off.

=========

Option A is correct because Remote Engagement with Twilio uses Salesforce named and external credentials, and users need access to the external credential principal to use those credentials. Salesforce Help for configuring Twilio credentials in Life Sciences Remote Engagement states that the Life Sciences Customer Engagement managed package includes the named and external credentials for Twilio. The same Salesforce Help result specifically references selecting External Credential Principal Access as part of the setup. This aligns directly with the error: the field sales rep cannot access the video service credentials, even though the Life Sciences Field Sales Representative permission set has been verified.

Option B is incorrect because the solution is not to manually provide the rep with a Twilio authentication token. That approach would be insecure and inconsistent with Salesforce’s named/external credential model. Credentials should be managed centrally through Salesforce configuration, not distributed directly to end users. Option C is also incorrect because “Twilio Users Public Group” is not the documented permission mechanism for accessing the video service credentials in Life Sciences Cloud Remote Engagement.

Salesforce’s broader named credential security documentation also explains that external credential principals can be mapped to permission sets and profiles so users can make callouts to external systems with the right access. That supports the need to grant External Credential Principal Access rather than changing the rep’s profile or sharing tokens manually.

=========

The correct answer is C because Salesforce Life Sciences Cloud provides the Lsc4ce.EmailQueueProcessor interface for using a third-party email service. Salesforce Help for using a third-party email service states that administrators should create a global Apex class that implements the Lsc4ce.EmailQueueProcessor interface. This interface is the supported extension point for handing off Life Sciences email operations to an external email provider instead of relying only on Salesforce’s standard email sending behavior and limits.

This scenario is specifically about emails sent from the Agentforce Life Sciences mobile app. Salesforce’s Field Email capability is designed to streamline compliant email creation, sending, and tracking for Life Sciences users, and the developer documentation describes LifeScienceEmail as representing a collection of sendable messages that manages creation, sending, and tracking of email communications. When an organization needs an external provider to send those emails, the custom Apex implementation must process the queued email operation and pass it to the third-party service.

Option A is incorrect because Lsc4ce.ExternalEmailHandler is not the interface identified by Salesforce for third-party email service handoff. Option B is also incorrect because Lsc4ce.MessagingService is not the documented Life Sciences email queue processing interface. Therefore, the consultant should implement Lsc4ce.EmailQueueProcessor .

=========

Option A is correct because Provider Activity Measure Type defines how engagement activities are measured and categorized in Activity Plans. Salesforce Help explains that an activity can be an interaction with a healthcare professional, such as a visit, and that a channel is the medium in which the interaction or activity occurs. This is exactly the requirement: Cumulus Pharma wants to distinguish email interactions from in-person visits so each channel can be counted separately against the field rep’s targets.

Salesforce Help for creating Activity Plans also states that admins should verify that a provider activity measure type has been created to track provider engagement activities. This confirms that Provider Activity Measure Type is the setup object used to define what kind of activity is being measured.

Option B, Provider Activity Goal, is not correct because it represents the target or goal assigned to providers or reps, such as six emails or three visits. It does not define the activity category itself. Option C, Provider Activity Plan Interaction, is also not the best answer because the question asks which configuration object defines the distinct interaction categories. The measure type is the categorization layer that can use Visit Channel, such as Email or In-Person, to count interactions separately. Therefore, Provider Activity Measure Type is the correct answer.

=========

The correct answer is C because Salesforce Life Sciences synchronization management guidance specifically positions Simulation Mode as the tool used to proactively identify and fix potential synchronization problems before they affect end users. Salesforce describes synchronization management as a way to ensure efficient synchronization by resolving errors quickly and using Simulation Mode to find potential problems before they impact users.

In this scenario, sales users are unable to view recently created records offline in the Agentforce Life Sciences mobile app because synchronization transactions have failed. Offline mobile availability depends on successful synchronization between Salesforce and the mobile app. A consultant should therefore recommend testing synchronization behavior in Simulation Mode, because it helps validate whether records, transactions, and configuration changes will synchronize successfully before users rely on them in the field.

Option A is not the best answer because Event Monitoring Logs are broader Salesforce security and activity logs; they are not the recommended Life Sciences-specific mechanism for proactively identifying synchronization transaction failures in the offline mobile synchronization process. Option B is also incorrect because warning emails notify users or administrators after certain conditions occur, but they do not test synchronization transactions or identify potential sync failures before users are affected. Simulation Mode is the most targeted and preventive administrative tool for this issue.

The correct answer is C because reverse affiliation creation is handled by the AffiliationReciprocalHandler . Salesforce Help for Life Sciences trigger handlers identifies AffiliationReciprocalHandler as the handler that manages reciprocal affiliations. The same documentation notes behavior related to reciprocal affiliations and affiliation type handling, which directly matches the scenario where a newly created affiliation should automatically create the reverse relationship.

Affiliation Reverse Role Mapping defines how the relationship role should translate between the original and reciprocal records. For example, if an HCP is “Attending” at an HCO, the reverse relationship may show the HCO as “Employing” or otherwise related to the HCP, depending on the configured mapping. However, defining the mapping alone does not execute the automation. The trigger handler must be active so that when users create a new Affiliation record, Salesforce can generate the reciprocal Affiliation record using the configured reverse role mapping.

Option A, AffiliationUniquenessHandler , is incorrect because uniqueness logic prevents duplicate or invalid affiliation records; it does not create the reverse relationship. Option B, HardAffiliationHandler , is also incorrect because it is not the handler identified for reciprocal affiliation generation. Since the missing behavior is automatic creation of the reverse affiliation, the consultant must enable AffiliationReciprocalHandler .

Option B, Product Item, is correct because Salesforce defines ProductItem as the object that represents the stock of a particular product at a particular location. Salesforce Field Service developer documentation states that ProductItem represents stock of a product at a location, such as items stored in a warehouse. The Field Service Inventory Management data model also states that inventory management starts with product items, which represent stock of a particular product at a particular location.

This exactly matches the reporting requirement. The analyst needs to calculate how much “Immunexis 50mg” exists in each sales rep’s trunk. In Salesforce inventory architecture, each rep’s trunk is modeled as a Location, and the stock quantity of a given Product2 at that Location is represented by Product Item records. Reporting on Product Item allows the analyst to group by Location, filter or group by Product, and calculate quantity or value.

Option A, Location Group, is incorrect because a location group organizes or groups locations; it does not represent the actual stock quantity of a specific product at an individual location. Option C, Product Request, is also incorrect because a product request is used for requesting or moving inventory, not for representing the on-hand inventory balance. Therefore, Product Item is the primary data source for this report.

The correct answer is B because the requirement is product-specific consent tracking. Salesforce’s Life Sciences Consent Management data model is designed for capturing and managing HCP consent and communication preferences. The model includes objects such as Communication Subscription , Communication Subscription Consent , Contact Point Consent , and Life Science Marketable Product , which together support consent management across communication channels and products.

When a field sales rep captures whether an HCP agrees to receive communications for a specific product, the consent must be tied both to the communication/contact point consent and to the relevant Life Sciences Marketable Product. A Life Sciences Marketable Product Consent record provides that product-level association, allowing the organization to track consent preferences for a particular product rather than only a general channel or subscription.

Option A is incorrect because Data Use Purpose represents the purpose for using data, such as marketing or communication, but it does not by itself create a product-specific consent relationship between an HCP’s contact point and a marketable product. Option C is also incorrect because adding a custom lookup to Communication Subscription Consent would be unnecessary and less aligned with the standard Life Sciences consent model. The best-practice configuration is to use the standard product-consent relationship by creating a Life Sciences Marketable Product Consent record linked to the relevant Contact Point Consent and product.

Option B is correct because Salesforce Life Sciences Cloud for Customer Engagement provides sample limit templates that help organizations enforce country-specific sampling rules. Salesforce Help states that Life Sciences Cloud includes a generic sample limit template and several country-specific templates by default. These templates are designed to support sample governance where regulations vary by country or region. In the scenario, Cumulus Pharma must comply with regional laws, such as Belgian requirements, while maintaining GxP standards for sample distribution. Using the default country-specific templates is the most appropriate standard configuration because it applies predefined sample-limit governance based on regional compliance expectations.

Option A is not the best answer because Territory Product Quantity Allocation is used to allocate product quantities by territory, but the requirement is about legal and GxP compliance by country. Allocation controls available quantities; it does not, by itself, represent the compliant sample-limit template framework. Option C is incorrect because manually adjusting Quantity On Hand on Product Item would change inventory balances directly and could create audit, traceability, and compliance risk. Product Item represents stock at a location, but manual quantity changes are not the correct way to enforce regional sampling laws.

Therefore, the consultant should use the default country-specific sample limit templates so sample distribution follows regional compliance rules while remaining aligned with Life Sciences Cloud’s controlled sample-management framework.

=========